Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Mirum Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of therapies.
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Phathom Pharmaceuticals is a biopharmaceutical company.
Immunovant is a clinical-stage biopharmaceutical company focused on enabling normal lives for patients with autoimmune diseases.
Iolyx Therapeutics is a biotechnology research and healthcare service provider for ocular diseases.
Scilex Pharmaceuticals is an emerging pharmaceutical company focused on acquiring and commercializing late-stage prescription products.
Sonoma Biotherapeutics develops engineered regulatory T-cell (Treg) therapies to treat autoimmune and inflammatory diseases.
Semnur Pharmaceuticals is a specialty pharmaceutical company focusing on clinical and commercial development of innovative products.
Iterum Therapeutics is a clinical-stage pharmaceutical company that develops significantly differentiated anti-infectives.
Seraxis is a privately owned biotechnology company.
Tarsus Pharmaceuticals is a clinical-stage biopharmaceutical company that develops treatments for diseases with high unmet need.
New Amsterdam is a clinical-stage company focused on the research and development of transformative therapies for cardio-metabolic diseases.
Rocket Pharmaceuticals is a biotech company that develops a pipeline of genetic therapies for rare childhood disorders.
Moximed develops innovative therapies for patients with knee osteoarthritis.
Gritstone bio is a biotechnology company that develops immunotherapies for cancer and infectious diseases.
Lassen Therapeutics develops antibody biotherapeutics to help improve the lives of patients suffering from serious diseases.
Radionetics Oncology is a pharmaceutical company that focuses on the discovery and development of novel radiotherapeutics.
Krystal Biotech provide significant clinical benefit for patients suffering from rare debilitating disorders..
Aptinyx Inc. is a biopharmaceutical company.
Allena Pharmaceuticals develops and commercializes non-systemic protein therapeutics to treat metabolic and orphan diseases.
Dascena develops machine learning algorithms to enable early disease intervention and improve care outcomes for patients.
Pardes Biosciences is a biotechnology company that develops and commercializes direct-acting antivirals for the treatment of coronavirus.
Scout Bi is a biotechnology company that specializes in veterinary, animal health, and gene therapy.
Frazier Healthcare Partners has invested in 49 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Frazier Healthcare Partners's top investment sectors include Biotechnology, Health Care, Pharmaceutical, Therapeutics, Biopharma. The firm invests across 14 different industry categories.
Among tracked funding rounds, Mirum Pharmaceuticals received $600.0M in a Post-IPO Debt round. Frazier Healthcare Partners's total known invested capital is $3.9B.
Frazier Healthcare Partners's average investment size is $80.3M across its portfolio of 49 companies.
Recent Frazier Healthcare Partners portfolio additions include Mirum Pharmaceuticals, Scholar Rock, Phathom Pharmaceuticals, Immunovant, Iolyx Therapeutics. These companies were founded in 2020 or later.